NovaBay Pharmaceuticals (NBY) Swings to Q4 Loss on Lighter Revs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts NBY Hot Sheet
Price: $1.95 --0%
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Financial Fact:
General and administrative: 2.22M
Today's EPS Names:
SFBC, KSBI, PVBK, More
Join SI Premium – FREE
NovaBay Pharmaceuticals (NYSE: NBY) reported Q4 EPS of ($0.13), versus $0.01 reported last year. Revenue for the quarter came in at $1.23 million, versus $3.04 million reported last year.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
For earnings history and earnings-related data on NovaBay Pharmaceuticals (NBY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Orion Marine Group (ORN) Tops Q3 EPS by 3c ; Offers Guidance
- Oceanfirst Financial (OCFC) Tops Q3 EPS by 8c
- First Busey (BUSE) Misses Q3 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
